2 Attractive Large Caps on Sale After Q2 Earnings

Key Points

  • For S&P 500 companies that fell short of Wall Street’s Q2 forecasts, macroeconomic weakness, soft demand and cost inflation are common themes.
  • Interpublic Group of Companies fell short on revenue, impacted by macro uncertainty that caused clients to spend cautiously during the period.
  • In the back half of the year, IPG is expected to return to top line growth thanks to some large new business wins.
  • Equifax reported slightly lower-than-expected revenue, leading to a $20 share price selloff that extended to a 15% downturn last week. 
  • Equifax is trading at 23x next year’s earnings estimate - well below its five-year average P/E ratio of 30x, a reversion to which implies 30% upside.
  • 5 stocks we like better than Interpublic Group of Companies

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

Should you invest $1,000 in Interpublic Group of Companies right now?

Before you consider Interpublic Group of Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Interpublic Group of Companies wasn't on the list.

While Interpublic Group of Companies currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Interpublic Group of Companies (IPG)
4.6861 of 5 stars
$30.72+0.6%4.30%10.93Hold$35.13
Equifax (EFX)
4.8785 of 5 stars
$227.05+1.1%0.69%50.57Moderate Buy$270.19
Bristol-Myers Squibb (BMY)
4.9853 of 5 stars
$43.99+0.7%5.46%-14.19Hold$60.00
Pfizer (PFE)
4.9804 of 5 stars
$27.81+0.4%6.04%-463.42Hold$36.00
Berkshire Hathaway (BRK.B)
0.6172 of 5 stars
$400.87+0.1%N/A9.06Hold$414.00
Acxiom (ACXM)
0 of 5 stars
$48.48flatN/AN/AN/A
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

Biotech Boom: Stocks Skyrocketing & What's Next

Biotech Boom: Stocks Skyrocketing & What's Next

Dive into biotech's latest trends with Dylan Jovine: weight loss breakthroughs, smart chemo innovations, and expert stock evaluation tips.

Search Headlines: